A survey of zeb1, twist and claudin 1 and 4 expression during placental development and disease

APMIS

Volumn 122, Issue 6, 2014, Pages 530-538

  Pirinen, Elina ^a   Soini, Ylermi ^a,b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Claudin; Placenta; Twist; Zeb1

Indexed keywords

CLAUDIN 1; CLAUDIN 4; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR ZEB1;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MESENCHYME CELL; MOLAR DISEASE; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY TOXEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; TROPHOBLAST;

CLAUDIN; PLACENTA; TWIST; ZEB1;

BIOLOGICAL MARKERS; CHORIOAMNIONITIS; CHROMOSOME ABERRATIONS; CLAUDIN-1; CLAUDIN-4; DIABETES, GESTATIONAL; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; PLACENTA DISEASES; PLACENTA PREVIA; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; TRANSCRIPTION FACTORS; TWIST TRANSCRIPTION FACTOR; UTERINE NEOPLASMS;

EID: 84901243272     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12187     Document Type: Article

References (46)

1. Guaita S, Puig I, Franci C, Garrido M, Dominguez D, Batlle E, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002;277:39209-16.
2. Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, et al. DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 2005;24:2375-85.
3. Arima Y, Hayashi H, Sasaki M, Hosonaga M, Goto TM, Chiyoda T, et al. Induction of ZEB proteins by inactivation of RB protein is key determinant of mesenchymal phenotype of breast cancer. J Biol Chem 2012;287:7896-906.
4. Shin JO, Nakagawa E, Kim EJ, Cho KW, Lee JM, Cho SW, et al. miR-200b regulates cell migration via Zeb family during mouse palate development. Histochem Cell Biol 2012;137:459-70.
5. Bellon E, Luyten FP, Tylzanowski P. delta-EF1 is a negative regulator of Ihh in the developing growth plate. J Cell Biol 2009;187:685-99.
6. Darling DS, Stearman RP, Qi Y, Qiu MS, Feller JP. Expression of Zfhep/deltaEF1 protein in palate, neural progenitors, and differentiated neurons. Gene Expr Patterns 2003;3:709-17.
7. Tylzanowski P, De Valck D, Maes V, Peeters J, Luyten FP. Zfhx1a and Zfhx1b mRNAs have non-overlapping expression domains during chick and mouse midgestation limb development. Gene Expr Patterns 2003;3:39-42.
8. Jethanandani P, Kramer RH. Alpha7 integrin expression is negatively regulated by deltaEF1 during skeletal myogenesis. J Biol Chem 2005;280:36037-46.
9. Chen J, Yusuf I, Andersen HM, Fruman DA. FOXO transcription factors cooperate with delta EF1 to activate growth suppressive genes in B lymphocytes. J Immunol 2006;176:2711-21.
10. Arnold CN, Pirie E, Dosenovic P, McInerney GM, Xia Y, Wang N, et al. A forward genetic screen reveals roles for Nfkbid, Zeb1, and Ruvbl2 in humoral immunity. Proc Natl Acad Sci U S A 2012;109:12286-93.
11. Šošić D, Richardson JA, Yu K, Ornitz DM, Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 2003;112:169-80.
12. O'Rourke MP, Soo K, Behringer RR, Hui CC, Tam PP. Twist plays an essential role in FGF and SHH signal transduction during mouse limb development. Dev Biol 2002;248:143-56.
13. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, et al. Twist is a potential oncogene that inhibits apoptosis. Genes Dev 1999;13:2207-17.
14. Dollfus H, Kumaramanickavel G, Biswas P, Stoetzel C, Quillet R, Denton M, et al. Identification of a new TWIST mutation (7p21) with variable eyelid manifestations supports locus homogeneity of BPES at 3q22. J Med Genet 2001;38:470-2.
15. Yousfi M, Lasmoles F, Marie PJ. TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts. Biochem Biophys Res Commun 2002a;297:641-4.
16. Yousfi M, Lasmoles F, El Ghouzzi V, Marie PJ. Twist haploinsufficiency in Saethre-Chotzen syndrome induces calvarial osteoblast apoptosis due to increased TNFalpha expression and caspase-2 activation. Hum Mol Genet 2002b;11:359-69.
17. Villavicencio EH, Yoon JW, Frank DJ, Füchtbauer EM, Walterhouse DO, Iannaccone PM. Cooperative E-box regulation of human GLI1 by TWIST and USF. Genesis 2002;32:247-58.
18. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT, et al. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 2004;23:474-82.
19. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-39.
20. van Doorn R, Dijkman R, Vermeer MH, Out-Luiting JJ, van der Raaij-Helmer EM, Willemze R, et al. Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis. Cancer Res 2004;64:5578-86.
21. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta 2008;1778:631-45.
22. Mineta K, Yamamoto Y, Yamazaki Y, Tanaka H, Tada Y, Saito K, et al. Predicted expansion of the claudin multigene family. FEBS Lett 2011;585:606-12.
23. Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta 2008;1778:588-600.
24. Kirk A, Campbell S, Bass P, Mason J, Collins J. Differential expression of claudin tight junction proteins in the human cortical nephron. Nephrol Dial Transplant 2010;25:2107-19.
25. Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 2006;6:581-8.
26. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002;156:1099-111.
27. Fujita H, Hamazaki Y, Noda Y, Oshima M, Minato N. Claudin-4 deficiency results in urothelial hyperplasia and lethal hydronephrosis. PLoS ONE 2012;7:e52272.
28. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, Wölk B, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 2007;446:801-5.
29. Van Itallie CM, Betts L, Smedley JG 3rd, McClane BA, Anderson JM. Structure of the claudin-binding domain of Clostridium perfringens enterotoxin. J Biol Chem 2008;283:268-74.
30. Hou J, Renigunta A, Gomes AS, Hou M, Paul DL, Waldegger S, et al. Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A 2009;106:15350-5.
31. Hou J. The yin and yang of claudin-14 function in human diseases. Ann N Y Acad Sci 2012;1258:185-90.
32. Gow A, Southwood CM, Li JS, Pariali M, Riordan GP, Brodie SE, et al. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 1999;99:649-59.
33. Merikallio H, Kaarteenaho R, Pääkkö P, Lehtonen S, Hirvikoski P, Mäkitaro R, et al. Zeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudins. J Clin Pathol 2011;64:136-40.
34. Singh AB, Sharma A, Smith JJ, Krishnan M, Chen X, Eschrich S, et al. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. Gastroenterology 2011;141:2140-53.
35. Lee KW, Lee NK, Kim JH, Kang MS, Yoo HY, Kim HH, et al. Twist1 causes the transcriptional repression of claudin-4 with prognostic significance in esophageal cancer. Biochem Biophys Res Commun 2012;423:454-60.
36. Inuzuka T, Tsuda M, Kawaguchi H, Ohba Y. Transcription factor 8 activates R-Ras to regulate angiogenesis. Biochem Biophys Res Commun 2009a;379:510-3.
37. Inuzuka T, Tsuda M, Tanaka S, Kawaguchi H, Higashi Y, Ohba Y. Integral role of transcription factor 8 in the negative regulation of tumor angiogenesis. Cancer Res 2009b;69:1678-84.
38. Hurt EM, Saykally JN, Anose BM, Kalli KR, Sanders MM. Expression of the ZEB1 (deltaEF1) transcription factor in human: additional insights. Mol Cell Biochem 2008;318:89-99.
39. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci U S A 2010;107:20828-33.
40. Mironchik Y, Winnard PT Jr, Vesuna F, Kato Y, Wildes F, Pathak AP, et al. Twist overexpression induces in vivo angiogenesis and correlates with chromosomal instability in breast cancer. Cancer Res 2005;65:10801-9.
41. Hu L, Roth JM, Brooks P, Ibrahim S, Karpatkin S. Twist is required for thrombin-induced tumor angiogenesis and growth. Cancer Res 2008;68:4296-302.
42. Ng YH, Zhu H, Leung PC. Twist regulates cadherin-mediated differentiation and fusion of human trophoblastic cells. J Clin Endocrinol Metab 2011;96:3881-90.
43. Soini Y, Kinnula V, Kahlos K, Pääkkö P. Claudins in differential diagnosis between mesothelioma and metastatic adenocarcinoma of the pleura. J Clin Pathol 2006;59:250-4.
44. Liévano S, Alarcón L, Chávez-Munguía B, González-Mariscal L. Endothelia of term human placentae display diminished expression of tight junction proteins during preeclampsia. Cell Tissue Res 2006;324:433-48.
45. Hawkins BT, Lundeen TF, Norwood KM, Brooks HL, Egleton RD. Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases. Diabetologia 2007;50:202-11.
46. Villarroel M, García-Ramírez M, Corraliza L, Hernández C, Simó R. High glucose concentration leads to differential expression of tight junction proteins in human retinal pigment epithelial cells. Endocrinol Nutr 2009;56:53-8.